Hardware Podcasts

#469: Why Market Strategy Comes First in MedTech Development

Global Medical Device Podcast · 21 Sept 2026 · 39m · Episode 469

What this episode covers

Shai Policker, Managing Partner at Edge Medical Ventures, explains how his firm reverses the traditional MedTech development paradigm by identifying validated clinical needs from multinational corporations before prototyping. He details how this approach allows for early mapping of reimbursement codes and regulatory pathways, citing examples like Urologic Health’s non-invasive urodynamics and Xero Medical’s smart surgical drains. Policker emphasizes that successful products must offer dramatic clinical improvements while maintaining familiar form factors to leverage existing 510(k) predicates and billing mechanisms.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Edge Medical Ventures, Urologic Health, Xero Medical, Synchrony Medical, Endostim, Greenlight Guru
Also
510(k), FDA, Medicare

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

    Crowdfunding & preordersValidation & product-market fit
    8 chapters

  • Product Startup · 29m

    074: Medical Device Product Development Best Practices

    Rob Crowder, Head of Product at Nutromics, explains how his team uses user journey mapping to navigate the complexities of developing medical sensor devices, specifically the Neutromics wearable patch. He details the process of validating unmet needs in high-stakes areas like therapeutic drug monitoring for vancomycin, emphasizing the need to focus on specific indications like bacteremia to ensure clinical utility and commercial viability. Crowder contrasts this rigorous MedTech evidence bar with general product development, highlighting the importance of identifying all stakeholders—patients, clinicians, and payers—early in the design phase to avoid feature creep and resource burnout.

    Medical & health devicesValidation & product-market fit
    7 chapters

  • Being an Engineer · 46m

    S5E8 Aaron Call | How to Find Money for MedTech Startups

    Aaron Call, founding principal of Jaunt, explains how his company helps MedTech startups navigate market intelligence and fundraising by focusing on customer discovery rather than just technical feasibility. He distinguishes between sustaining and disruptive innovation, detailing how Jaunt uses qualitative and quantitative research to validate product-market fit for Class I and II devices. Call also outlines the current venture capital landscape, noting the shift toward funding only exceptional companies, and discusses the integration of AI in healthcare administration and device development.

    Validation & product-market fitFundraising & investors
    9 chapters

  • Product Startup · 23m

    104: Medical Device Certification vs Wellness Device

    Bryon Bhagwandin, a medical device entrepreneur with a PhD from the University of Washington, explains the critical differences between wellness and medical devices, emphasizing that medical clearance allows sales into clinical settings. He details the three pillars of medical certification: safety, efficacy (verification and validation), and manufacturing consistency, noting that hand-built prototypes cannot be certified without statistical proof of uniform production. Bhagwandin advises that while wellness devices are cheaper to launch, starting with a medical device strategy is often superior because it opens higher-margin B2B channels and allows for easier transition to consumer markets. He also suggests that founders can leverage user data from existing wellness products to support the regulatory submission of a redesigned medical version, provided they maintain rigorous quality and avoid feature creep.

    Certification & complianceValidation & product-market fit
    8 chapters

  • The Builder Circle · 1h 11m

    S2 E2: Demystifying Medical Device and System Development with Alan Cohen

    Alan Cohen, author of 'Prototype to Product' and a systems engineering manager specializing in radiation therapy devices, explains the complexities of medical device development to host Sera Evcimen. Cohen emphasizes that successful startups often emerge from collaborations between engineers and clinicians, and he details the critical importance of understanding reimbursement models, specifically CPT codes, before building a product. He advocates for using Fault Tree Analysis over FMEA for complex systems to manage risk efficiently and advises founders to balance lean documentation with rigorous process adherence to satisfy FDA requirements without over-engineering.

    Medical & health devicesValidation & product-market fit
    10 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.